Exam 1 (chapter 5 catecholamines) | Quizlet

0.0(0)
studied byStudied by 0 people
full-widthCall with Kai
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/182

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

183 Terms

1
New cards

catecholamines are

monoamines (a catechol + an amine group)

2
New cards

catecholamines are synthesized by a multistep pathway in which _____ catalyzes the ______ step

tyrosine hydroxylase

rate-limiting

3
New cards

factors that affect TH activity

1. DA and NE levels in the nerve terminal (negative feedback)

2. cell firing stimulates TH activity through phosphorylation of the enzyme by protein kinases

4
New cards

what catalyzes the conversion of DOPa to dopamine

aromatic amino acid decarboxylase (AADC)

5
New cards

what catalyzes the conversion of dopamine to norepinephrine

dopamine - b - hydroxylase (DBH)

6
New cards

drugs that reduce synthesis inhibit one of the enzymes: ________ blocks _______

a-methyl-para-tyrosine (AMPT) blocks TH

7
New cards

catecholamine storage and release are regulated by

vesicular uptake

autoreceptor activity

cell firing rate

8
New cards

catecholamines are located into synaptic vesicles by

vesicular monoamine transporters (VMAT)

9
New cards

VMAT can be blocked by

reserpine

10
New cards

what is reserpine?

an irreversible inhibitor that causes sedation and depressive symptoms (blocks VMAT)

11
New cards

reversible inhibitors of VMAT are used to

reduce uncontrolled movements in huntington's disease and tardive dyskinesia

12
New cards

VMAT1 is found in the

adrenal medulla

13
New cards

VMAT2 is present in the

brain

14
New cards

both VMAT1 and VMAT2 can be

blocked by reserpine

15
New cards

reversible VMAT2 inhibitors:

tetrabenazine (trade name: Xenazine)

deutetrabenazine (austedo)

valibenazine (ingrezza)

16
New cards

types of catecholamines

dopamine

norepinephrine

epinephrine

17
New cards

adjective forms of the catecholamines

dopaminergic

noradrenergic

adrenergic

18
New cards

the ____ ___ secretes EPI and NE into the bloodstream where they act as ____

adrenal medulla

hormones

19
New cards

amines made by living organisms

biogenic amines

20
New cards

transmitters that have one amine group

monoamines

21
New cards

catecholamines are synthesized from

tyrosine

22
New cards

what is the rate-limiting enzyme

tyrosine-hydroxylase (TH)

23
New cards

catecholamines are synthesized from the precursor amino acid

tyrosine

24
New cards

tyrosine hydroxylase and aromatic amino acid decarboxylase are found in all

catecholaminergic neurons

25
New cards

dopamine - b - hydroxylase is present only in

cells that use norepinephrine as their neurotransmitter

26
New cards

catecholamine synthesis can be increased by administering

precursors such as tyrosine or L-DOPA

27
New cards

precursor used to treat Parkinson's disease

L-DOPA

28
New cards

the membrane of a dopaminergic neuron possesses

autoreceptors

when these are stimulated, they inhibit subsequent DA release by the cell

29
New cards

psychostimulants ____ and _____ cause release of catecholamines without nerve firing

amphetamine

methamphetamine

30
New cards

with amphetamine and methamphetamine in animals, they show increased activity; at high doses

stereotyped behaviors occur

31
New cards

in humans, drugs (psychostimulants) effects include

alertness, high energy levels, euphoria, insomnia

32
New cards

what are those stereotyped behaviors seen in lab animals taking psychostimulants?

intense sniffing, repetitive hand and limb movements, and licking and biting

33
New cards

dopamine release is inhibited by

autoreceptors

34
New cards

apart from autoreceptors, what also influences dopamine release

neuron firing pattern

35
New cards

what are the two forms of neuron firing pattern that influence dopamine release

single-spiking mode and burst mode

36
New cards

action potentials appear at irregular intervals

single-spiking mode

(tonic release)

37
New cards

type of release associated with single-spiking mode

tonic release

38
New cards

trains of 2-20 spikes at higher frequency, transmitter release occurring faster than it can be cleared and/or metabolized

burst mode

(phasic release)

39
New cards

type of release associated with burst mode

phasic release

40
New cards

the autoreceptors inhibit neurotransmitter release through two combined mechanisms

1) inhibiting action of voltage-gated ca2+ channels - reduces DA release by directly reducing amount of activity mediated Ca2+ influx needed for vesicular exocytosis

2) enhancing the opening of a type of voltage-gated K+ channel - indirectly reduces Ca2+ influx by shortening the duration of action potentials

41
New cards

what catecholamine axons form en passant (in passing) synapses

dopamine and norepinephrine

42
New cards

fibers have repeated swellings called _______ along their length, filled with synaptic vesicles

varicosities

43
New cards

what are some details about varicosities and their role as releasing sites for DA?

but only 30% of varicosities have release sites for Dopamine; questions regarding their function remain

44
New cards

after catecholamines are released what happens?

they are recycled by the process of reuptake

45
New cards

how does reuptake work for DA and NE?

DA and NE transporters return the transmitters to the releasing cell for breakdown or repackaging into vesicles

46
New cards

uptake of catecholamines through

by postsynaptic cell or glial cells by non-selective transporters

47
New cards

what do transporter-blocking drugs do?

enhance DA or NE transmission by increasing the amount of the NT available

48
New cards

compounds that block both DA and NE reuptake include

methylphenidate (Ritalin) and amphetamine (Adderall)

49
New cards

what are Ritalin and Adderall typically for?

standard treatments for ADHD

50
New cards

compounds that block NE transporters include

atomoxetine (Strattera) and reboxetine (edronax)

51
New cards

?what is Strattera for

newer adhd medication

52
New cards

what is reboxetine for?

newer generation antidepressant drug

53
New cards

compounds that block combinations of catecholamine and serotonin (5-HT) reuptake:

tricyclic antidepressants, which block the NE and 5-HT transporters, and cocaine, which inhibits reuptake of all three major monoamine transmitters

54
New cards

what are the three monoamine transmitters?

DA, NE, and 5-HT

55
New cards

extracellular DA levels are strongly elevated by

treatment with a DA reuptake inhibitor

56
New cards

catecholamine levels are regulated by

metabolizing enzymes

57
New cards

breakdown of catecholamines involves

monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT)

58
New cards

what metabolizing enzyme was used to treat depression but had dangerous side effects

nonselective MAO inhibitors

59
New cards

types of selective MAO inhibitors

moclobemide (MAO-A) selegiline (eldepryl) rasagiline (azilect) (MAO-B)

60
New cards

selective MAO inhibitors used for depression

moclobemide (MAO-A)

61
New cards

selective MAO inhibitors used for Parkinson's disease

Selegiline (Eldepryl) and rasagiline (Azilect)

62
New cards

what are the two types of MAO

MAO-A and MAO-B

63
New cards

MAO expressed by catecholamine neurons

MAO-A

64
New cards

MAO found in other types of neurons and glial cells (astrocytes)

MAO-B

65
New cards

nonselective mao inhibitors block both

MAO A and MAOB

66
New cards

what nonselective MAo inhibitors are used to treat depression and have dangerous side effects

phenelzine (nardil)

tranylcypromine (parnate)

67
New cards

COMT acts on compounds containing the

catechol structure

68
New cards

action of MAO and COMT produce metabolites:

DA metabolite

NE metabolites

69
New cards

what is the DA metabolite

homovanillic acid (HVA)

70
New cards

what is the NE metabolites?

3-methoxy-4-hydroxy-phenylglycol (MHPG) in the brain and vanillymandelic acid (VMA) in PNS

71
New cards

levels of metabolites in blood, urine, and CSF provide an indication of

catecholaminergic activity

72
New cards

COMT inhibitors that enhance l-DOPA availability in Parkinson's patients

entacapone (comtan)

opiscapone (ongentys)

tolcapone (tasmar)

73
New cards

What type of compound would reduce the availability of NE?

b. Tyrosine hydroxylase inhibitor

74
New cards

two important dopaminergic cells groups are found in the

midbrain

(A9 and A10)

75
New cards

A9 is in the

substantia nigra (midbrain)

axons ascend to the dorsal striatum in the forebrain (the nigrostriatal tract)

76
New cards

A10 is in the

ventral tegmental area (VTA)

77
New cards

pathways of the A10

mesolimbic dopamine pathway

mesocortical dopamine pathway

78
New cards

VTA to limbic system

mesolimbic dopamine pathway

79
New cards

VTA to the cerebral cortex

mesocortical dopamine mathway

80
New cards

a small groups of cells in the hypothalamus gives rise to the

tuberohypophyseal dopamine pathway

81
New cards

important in controlling secretion of prolactin by the pituitary gland

tuberohypophyseal dopamine pathway

82
New cards

there are also DA-containing neurons within

sensory structures such as the olfactory bulbs and the retina

83
New cards

the ascending DA systems can be divided into

3 pathways

nigrostriatal pathway

mesolimbic pathway

mesocortical pathway

84
New cards

the nigrostriatal pathway originates in the _____ and innervates the _______

substantia nigra (a9 cell cluster)

caudate-putamen (dorsal striatum)

85
New cards

the mesolimbic pathway originates in the _____and innervates various ____

VTA (A10 cell cluster)

limbic system structures (nucleus accumbens, hippocampus, lateral septum, amygdala)

86
New cards

the mesocortical pathway originates in the _____ and innervates the

VTA

cerebral cortex

87
New cards

______ dopamine pathways have been implicated in several important behavioral functions

ascending

88
New cards

____ tract facilitates voluntary movement

nigrostriatal

89
New cards

parkinson's disease has been linked with

loss of DA neurons in the substantia nigra

90
New cards

mutations in genes for TH, AADC,

tetrahydrobiopterin (TH cofactor)

(rare inborn errors of metabolism)

91
New cards

experimental lesions of the nigrostriatal tract by

neurotoxins

(6-hydroxydopamine 6-OHDA and 1-methyl-4-phenyl-1,2,3,4,5,6 - tetrayhydropyridine)

92
New cards

mice have been genetically engineered to lack

dopamine dopamine

93
New cards

what is a dopamine-deficient (DD) mouse

gene for TH is knocked out but not the gene for DBH - NE can be synthesized but not DA

94
New cards

DD mice exhibit severe

aphagia, adipsia, and hypoactivity

95
New cards

lack of feeding behavior

aphagia

96
New cards

lack of drinking

adipsia

97
New cards

the behaviors of DD mouse can be restored by

L-DOPA

98
New cards

mouse models confirmed a critical role for the ___ ___ in many of the activational, motivational, and cognitive functions of DA

dorsal striatum

99
New cards

activates arousal and locomotor behavior: different neurons mediate the effects of rewarding and aversive stimuli

mesolimbic dopamine pathway

100
New cards

input to the PFC helps regulate cognitive functions such as attention and working memory

mesocortical pathway